Starquest Capital Invests $73M In Chinese Drug E-Commerce Firm

Chinese pharmaceutical e-commerce company Miaoshou Doctor has secured an RMB500 million (US$72.77 million) series C+ round of financing led by Chinese private equity firm Starquest Capital, with the participation of investors like Sequoia Capital China, Sequoia confirmed to China Money Network on Monday.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets